The next generation breast density assessment

Quantra™ 2.2 breast density assessment software

Quantra™ 2.2: The latest standard for AI powered breast density assessment

As awareness of breast density as a risk factor for cancer grows, so does the need for accurate, more consistent analysis. Quantra™ breast density assessment software enables quick and accurate breast density measurements across your entire patient population, elevating your standard of care and standardising reporting across your entire radiology practice.

Discover the difference with Quantra™ 2.2

By offering texture and pattern analysis, Quantra™ 2.2 brings more consistent, more reliable scoring. It delivers the objective assessment you need to confidently customise your patient care decisions.

  • A Breast Density estimation algorithm, powered by machine learning
  • Texture and pattern analysis calculations
  • BI-RADS 5th edition-like breast density scores

Pair the 3D Mammography™ Exam with Quantra™ 2.2 for an improved breast density offering

Dense breast tissue can obscure lesions on a traditional mammogram, making cancers harder to detect and recalls more likely. This is particularly concerning because as the density of the breast increases, so does the risk of breast cancer.

Now you have the ability to offer Quantra™ 2.2 and the 3Dimensions™ 3D Mammography™ system together, allowing you to benefit from a faster workflow and women to benefit from an improved solution for breast density.

  • Proven to be superior for women with dense breasts compared with 2D alone1,2
  • Clinically proven to reduce the chance of recalls by up to 40%1,3-8
  • Paired with Quantra™ 2.2, to offer you and your patients a more reliable outcome

  1. Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507.
  2. FDA submissions P080003, P080003/S001 P080003/S0056.
  3. Rafferty EA, Durand MA, Conant EF, et al. Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts. JAMA. 2016;315(16): 1784-6.
  4. Data On File: DHM-06039 Rev 002 Jennifer Bartoshevich, Teri Orefice, Sajjad Mansoor, Internal Study comparing Hologic®’s flat paddle to the SmartCurve paddle (18x24cm) (2017).
  5. Bernardi D, Macaskill P, Pellegrini M, et. al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.
  6. McDonald ES, Oustimov A, Weinstein SP, et al. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening. JAMA Oncol. 2016 Jun 1;2(6):737-43.
  7. Zuckerman SP, Conant EF, Keller BM, et al. Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology. 2016 Dec;281(3):730-736
  8. Skaane P, Bandos A, Eben EB, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014 Jun;271(3):655-63.
ce mark
0050 TruNode® 2797 All Other Products
Hologic BV, DA Vincilaan 5,
1930 Zaventem, Belgium

Product Notice

You are about to access medical systems information on the Hologic 3Dimensions™ Mammography System European Website. Product availability differs by region and country and is subject to varied regulatory requirements.

The content of this site is reserved for Health Care Professionals only.

I am a Health Care Professional or similar.

Je suis un professionnel de santé ou assimilé.

Je ne suis pas un professionnel de santé ou assimilé.